Filing Overview
Haoxi Health Technology Limited filed a Form 6-K for March 2024. On March 8, 2024, EF Hutton LLC, as representative of the IPO underwriters, exercised its over-allotment option in full.
Offering and Financial Impact
- The Company sold an additional 360,000 Class A ordinary shares at the IPO price of US$4.00 per share.
- Gross proceeds from the initial public offering, including the over-allotment shares, totaled US$11.04 million before underwriting discounts and related expenses.
- The filing does not provide net proceeds, cash balances, debt, revenue, profit, cash flow, margins, or liquidity metrics.
Material Changes and Outlook
The filing reports completion of the IPO over-allotment exercise and does not provide operating results, management guidance, forecasts, or broader business outlook commentary.
The filing includes customary securities-law language stating that it is not an offer to sell or a solicitation to buy securities where such activity would be unlawful without required registration or qualification.
Investor Verification Points
- Verify the final number of Class A ordinary shares outstanding following the over-allotment issuance.
- Review subsequent filings for the net IPO proceeds after underwriting discounts and offering expenses.
- Assess how the offering proceeds are allocated and whether they materially change the Company’s liquidity or capital structure.
- Review the Company’s Form 20-F and subsequent reports for operating performance, risks, related-party matters, and use-of-proceeds disclosures.